15.01.2015 Views

Lung function measurements in children - copsac

Lung function measurements in children - copsac

Lung function measurements in children - copsac

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

RA 08 TSM 133; Respiratory Care Center; Hämeenl<strong>in</strong>na, F<strong>in</strong>land) as previously detailed (25). The<br />

result was assessed by PTcO2 <strong>in</strong> accordance with previous sensitivity analyses (25, 27) and the provocative<br />

dose caus<strong>in</strong>g a 15% drop <strong>in</strong> PTcO2 was estimated from the dose response curves fitted<br />

with a logistic <strong>function</strong>.<br />

Bronchiolitis<br />

Bronchiolitis was def<strong>in</strong>ed as an acute respiratory illness before the age of 2 years based on symptoms<br />

of coryza progress<strong>in</strong>g over a few days to cough, tachypnea, chest retraction and wide spread<br />

crackles, wheezes or both (28) diagnosed by the COPSAC cl<strong>in</strong>ical research unit doctor or admission<br />

acutely to the local hospital for such symptoms.<br />

RSV bronchiolitis<br />

RSV bronchiolitis was def<strong>in</strong>ed as bronchiolitis with a positive ELISA test for RSV <strong>in</strong>fection with<strong>in</strong><br />

10 days of the acute episode.<br />

Acute severe wheezy exacerbations<br />

Acute severe wheezy exacerbations was def<strong>in</strong>ed as an acute obstructive respiratory illness diagnosed<br />

by the COPSAC cl<strong>in</strong>ical research unit doctor and judged to be a severity requir<strong>in</strong>g treatment<br />

with oral or high-dose <strong>in</strong>haled corticosteroids (>800 micg budesonide/day) or hospitalizations<br />

caused by airway symptoms where an anti-asthmatic drug was prescribed (pseudocroup episodes<br />

were excluded).<br />

Control group<br />

Children who developed neither bronchiolitis nor acute wheezy exacerbations before age 2 were<br />

considered as controls.<br />

Statistics<br />

<strong>Lung</strong> <strong>function</strong> measurement data (FEV 0.5 and PD15) were calibrated with lifespan and birth length<br />

<strong>in</strong> accordance with previous lung <strong>function</strong> analyses of the newborn (29) calculated by a generalized<br />

l<strong>in</strong>ear model. Lifespan at exam<strong>in</strong>ation date was calculated as the sum of estimated gestational age <strong>in</strong><br />

weeks and weeks s<strong>in</strong>ce birth. The lung <strong>function</strong> <strong>measurements</strong> were log transformed and we used a<br />

multivariable logistic regression model to calculate adjusted odds ratios and 95% confidence <strong>in</strong>tervals<br />

us<strong>in</strong>g SAS version 9.1. Outcome variable was RSV bronchiolitis compared to control group.<br />

Confounder adjustment <strong>in</strong>cluded mothers smok<strong>in</strong>g dur<strong>in</strong>g 3 rd trimester (dichotomized) and gender.<br />

4

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!